- Safety of glecaprevir/pibrentasvir among Saudi population at a single tertiary hospital.
| Outcomes | n (%) | 95% CI |
|---|---|---|
| Elevation in ALT | ||
| Grade 0 | 83 (91.2) | 82.2-95.4 |
| Grade I | 6 (6.6) | 2.4-13.7 |
| Grade II | 2 (2.2) | 0.3-7.6 |
| No data | 1 (1.1) | - |
| Elevation in bilirubin | ||
| Grade 0 | 82 (89.1) | 80.9-94.7 |
| Grade I | 4 (4.3) | 1.2-10.8 |
| Grade II | 2 (2.2) | 0.3-7.6 |
| Grade III | 3 (3.3) | 0.7-9.2 |
| No data | 1 (1.1) | - |
| Elevation in AST | ||
| Grade 0 | 84 (91.3) | 83.6-96.2 |
| Grade I | 5 (5.4) | 1.8-12.2 |
| Grade II | 2 (2.2) | 0.3-7.6 |
| Grade III | 1 (1.1) | - |
| Skin itching | ||
| Grade I | 1 (1.1) | - |
Values are presented as numbers and precentages and and 95% confidence interval (CI). ALT: alanine aminotransferase, AST: aspartate transferase